References
- Gil J , StembalskaA , PeszKA , SasiadekMM . Cancer stem cells: the theory and perspectives in cancer therapy . J. App. Genet.49 ( 2 ), 193 – 199 ( 2008 ).
- Costa FF , LeBlanc K , BrodinB . Concise review: cancer/testis antigens, stem cells and cancer . Stem Cells25 ( 3 ), 707 – 711 ( 2007 ).
- Takahashi K , YamanakaS . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors . Cell126 ( 4 ), 663 – 676 ( 2006 ).
- Sarkar S , GoldgarS , BylerS , RosenthalS , HeerbothS . Demethylation and reexpression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy . Epigenomics5 ( 1 ), 87 – 94 ( 2013 ). )
- Sarkar S , HornG , MoultonKet al. Cancer development, progression, and therapy: an epigenetic overview . Int. J. Mol. Sci.14 , 21087 – 21113 ( 2013 ).
- Lukasz J , AksoyFB , HersiHM , WantuchS , SawadoT . Identifying division symmetry of mouse embryonic stem cells: negative impact of DNA methyltransferases on symmetric self-renewal . Stem Cell Rep.1 , 360 – 369 ( 2013 ).
- Yuan X , CurtinJ , XiongYet al. Isolation of cancer stem cells from adult gliobalstoma multiform . Oncogene 23 , 9392 – 9400 ( 2004 ).
- Lee J , ChoiJH , JooCK . TGF-β1 regulates cell fate during epithelial-mesenchymal transition by upregulating survivin . Cell Death Dis.4 , e714 ( 2013 ).
- Matsumura N , HuangZ , MoriSet al. Epignetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer . Genome Res.21 , 74 – 82 ( 2011 ).
- Wong A , LeeS . Mechanisms of resistance to trastuzumab and novel therapeutic strategies in HER2-positive breast cancer . Int. J. Breast Cancer 2012 , 1 – 13 ( 2012 ).
- Byler S , GoldgarS , HeerbothS . Genetic and epigenetic aspects of breast cancer progression and therapy . Anticancer Res.34 ( 3 ), 1071–1077 ( 2014 ).
- Chaffer C , BrueckmannI Scheel . C et al. Normal and neoplastic nonstem cells can spontaneously covert to a stem-like state . Proc. Natl Acad. Sci. USA108 ( 19 ), 7950 – 7955 ( 2011 ).
- Mataga M , RosenthalS , HeerbothSet al. Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitors . Anticancer Res.32 , 2523 – 2530 ( 2012 ).
- Housman G, Mataga AM, Devalapalli A et al. Demethylation and re-expression of tumor suppressor genes by HDAC inhibitors and calpain inhibitors in cancer cells: a study related to synergistic type growth inhibition and reduction of motility. Presented at: The Epigenetics World Congress. MA, USA, 26–27 April 2011 (Abstract 206).
- Sarkar S , FallerDV . T-oligos inhibit growth and induce apoptosis in human ovarian cancer cells . Oligonucleotides21 ( 1 ), 47 – 53 ( 2011 ).
- Frew AJ , LindemannRK Martin . BP et al. Combination therapy of established cancer using a histone deacetylase inhibitor and a TRAIL receptor agonist . Proc. Natl Acad. Sci. USA105 ( 32 ), 11317 – 11322 ( 2008 ).
- Juergens R , WrangleJ Vendetti . F et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer . Cancer Discov.1 , 598 – 607 ( 2011 ).
- Johannessen CM , JohnsonLA , PiccioniFet al. A melanocyte lineage program confers resistance to MAP kinase pathway inhibition . Nature504 ( 7478 ), 138 – 142 ( 2013 ).
- Radpour R , BarekatiZ , KohlerCet al. Integrated epigenetics of human breast cancer: synoptic investigation of targeted genes, microRNAs and proteins upon demethylation treatment . PLoS ONE6 , e27355 ( 2011 ).
- Yang X , FergusonAT , NassSJet al. Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition . Cancer Res.60 , 6370 – 6394 ( 2000 ).
- Hanahan D , WeinberRA . The hallmarks of cancer: the next generation . Cell144 , 646 – 674 ( 2011 ).
- Fearon ER , VolgelsteinB . A genetic model for colorectal tumorigenesis . Cell61 , 759 – 767 ( 1990 ).
- Volgelstein B , KinzlerKW . Cancer genes and the pathways they control . Nat. Med.10 , 789 – 799 ( 2004 ).
- Stephens PJ , TarpeyPS , DaviesHet al. The landscape of cancer genes and mutational processes in breast cancer . Nature486 , 400 – 404 ( 2012 ).
- Sarkar S , LongacreM , TaturN , HeerbothS , LapinskaK . Histone deacetylases (HDACs): function, mechanism, and inhibition . In: Encyclopedia of Analytical Chemistry 2014 . MeyersRA (Ed.) John Wiley and Sons , Chichester, UK ( 2014 ). doi:10.1002/9780470027318.a9365 (Epub ahead of print) .